RAP2B and cancer: Although Rap2B exhibits upregulated expression in various cancer types, it displays a notably low incidence of somatic mutations in tumors-a striking contrast to the high mutational frequency observed in RAS proteins-indicating that the maintenance of high level of wild type Rap2B is somehow important for cancer development.